Wayne Kreppner
Corporate Officer/Principal bei EMBLEM CORP
Profil
Wayne Walter Kreppner is currently the Director at Impopharma, Inc. and the President-Medical Division at Emblem Corp.
He previously worked as the Vice President-Technology Transfer at Biovail Pharmaceuticals LLC from 1997 to 2008.
He also held positions as Vice President-Technical Operations at Acerus Pharmaceuticals Corp., Chief Operating Officer at Advanz Pharma Corp.
Ltd.
from 2014 to 2015, and President, Chief Operating Officer & Secretary at Concordia Pharmaceuticals (US), Inc. Mr. Kreppner received his undergraduate degree from the University of Western Ontario, his graduate degree from McMaster University, and his MBA from Richard Ivey School of Business.
Aktive Positionen von Wayne Kreppner
| Unternehmen | Position | Beginn |
|---|---|---|
| EMBLEM CORP | Corporate Officer/Principal | 01.11.2018 |
Impopharma, Inc.
 Impopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Impopharma, Inc. engages in developing and testing of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products. The company was founded by Hanna Piskorz and Harold Wulffhart in 1996 and is headquartered in Concord, Canada. | Direktor/Vorstandsmitglied | 05.10.2017 |
Ehemalige bekannte Positionen von Wayne Kreppner
| Unternehmen | Position | Ende |
|---|---|---|
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2008 |
Concordia Pharmaceuticals (US), Inc.
 Concordia Pharmaceuticals (US), Inc. Medical DistributorsDistribution Services Concordia Pharmaceuticals (US), Inc. distributes and supplies pharmaceutical products and orphan drugs. The company was founded on July 24, 2014 and is headquartered in Chicago, IL. | Präsident | - |
| ADVANZ PHARMA CORP. LIMITED | Präsident | - |
| ACERUS PHARMACEUTICALS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 17.01.2012 |
Ausbildung von Wayne Kreppner
| University of Western Ontario | Undergraduate Degree |
| McMaster University | Graduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
Biovail Pharmaceuticals LLC
Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Health Technology |
Concordia Pharmaceuticals (US), Inc.
Concordia Pharmaceuticals (US), Inc. Medical DistributorsDistribution Services Concordia Pharmaceuticals (US), Inc. distributes and supplies pharmaceutical products and orphan drugs. The company was founded on July 24, 2014 and is headquartered in Chicago, IL. | Distribution Services |
Impopharma, Inc.
Impopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Impopharma, Inc. engages in developing and testing of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products. The company was founded by Hanna Piskorz and Harold Wulffhart in 1996 and is headquartered in Concord, Canada. | Commercial Services |
Emblem Corp.
 Emblem Corp. Pharmaceuticals: OtherHealth Technology Emblem Corp. engages in the sale of cannabis to patients who have received medical authorizations to acquire and use such cannabis. Its activities include production and sale of dried cannabis to qualified patients. The Company was founded on February 25, 2008 and is headquartered in Toronto, Canada. | Health Technology |
